Back to Search
Start Over
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence.
- Source :
- Neuro-Oncology; Nov2020, Vol. 22 Issue 11, p1580-1590, 11p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 15228517
- Volume :
- 22
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 147262251
- Full Text :
- https://doi.org/10.1093/neuonc/noaa059